Retracted: Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma

{{output}}

[This retracts the article DOI: 10.1155/2022/6957580.]. Copyright © 2023 Disease Markers.

请注册登录后继续浏览